{"name":"Inozyme Pharma","slug":"inozyme-pharma","ticker":"","exchange":"","domain":"inozymepharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":83231000,"netIncome":-102024000,"cash":21081000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOV2FlU2I3aXgxTnF5VFhjMDJub1M1Nld1QTN2QkxNMlI3SGNpclh5ZlZGS2pTaTlJakotR21rN0tMclVEcVVoN3hETDRUdU8xdUVITk9MYW1nQjFjYksxOEpjNEtGRHY3cmpvWFdzV2lpRFByN01KT3pTNFNlUVFUUDFpN2JhOVIzOFNJbnIweTFUdlFLRUN6M3Y3R2k?oc=5","date":"2025-07-10","type":"pipeline","source":"Yahoo Finance","summary":"BioMarin Pharmaceutical (BMRN) Finalizes the Acquisition of Inozyme Pharma - Yahoo Finance","headline":"BioMarin Pharmaceutical (BMRN) Finalizes the Acquisition of Inozyme Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQYW9FcnVCNVBibmVyMkpsa3VQUkstc1p6X240VVl1VEhjSllYaDF4aldPaWhmM0dnaEQ5UkROOXdRZHg1REp3QjJzNFVpeDNXZHZyYzlpLWEtOFBEaVFUZHdlVk5vQUgzelJwMVljV2FaQVJPNjNieGt2WFZhczNjdXZmNEU1M0FmZ3RxcEx6RTBrcC1jN2VUUllMMTB2b1JTcUpQODJB?oc=5","date":"2025-07-01","type":"pipeline","source":"Contract Pharma","summary":"BioMarin Completes Acquisition of Inozyme Pharma for $270M - Contract Pharma","headline":"BioMarin Completes Acquisition of Inozyme Pharma for $270M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNdTJ1eE1DaDg5cXI3WUFldktkbHJONGRNX2gyaXVUaWxVbzllYzhMN0pvUWlES0VpaHhOa3hoNFZqQlZGdVZFamNkaVZydkVfUnN4aVpFTHJIVVlNZW1jZFFRWFNVNjUyZFpKQzJRMldIVGNRYmZYNy1PTlRIQkVzNTNoQ0hsRW1vOVo5dWtvV3lqb3dkUmdHYnJPVURoMENPZDJRcFRQOXZzMUhaa1ZWM016V2RVR3JJaWZjaW5Pd2NUbXNibzBDaERXbDNXZ0s5?oc=5","date":"2025-07-01","type":"pipeline","source":"Investing.com","summary":"BioMarin completes acquisition of Inozyme Pharma, triggers delisting from Nasdaq - Investing.com","headline":"BioMarin completes acquisition of Inozyme Pharma, triggers delisting from Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPM1c0d3dwN2t6YUdqeTlBMGpfWXkyOHN6SmpZYko3R0hERjFDaWxfaDNlTGVSX05WU1EtdjJaX3ZNQXRjQ1J5X3BNbTQ0NHlsaFUtbkI0SmhDWU9wd3FCcmFrVHBndTdPU1N0S0JaTDVTb3ZSdGt5cjlNT041djYtYV96SkstdENuX080a3pNWnE5NW5MNFh4dE53QUd6UU5mTEpweHQ2TXhLMVhvT1ZlXzlKQ1hjckZDZUMxNUYtRDU?oc=5","date":"2025-07-01","type":"pipeline","source":"Stock Titan","summary":"[SC TO-T/A] Inozyme Pharma, Inc. Amended Third-Party Tender Offer | INZY SEC Filing - Form SC TO-T/A - Stock Titan","headline":"[SC TO-T/A] Inozyme Pharma, Inc. Amended Third-Party Tender Offer | INZY SEC Filing - Form SC TO-T/A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQaDdDeUR4LVcxN2hWQS1xRDB5ZnVFc20tV0JacXIyMXFqMEJuTGp3MGUxYlVwZ2pkOFV5S3ZTQkR0ZE43YmN5dDhBWUpOOXE1WjY5cUp2RDV2dGMtdnF6c0gweTNTU3hUalBDc1RSTmx2bmNkTUV6NEFwOWYwLVJGQzZERQ?oc=5","date":"2025-05-19","type":"deal","source":"Pharmaceutical Technology","summary":"BioMarin agrees to acquire Inozyme for $270m - Pharmaceutical Technology","headline":"BioMarin agrees to acquire Inozyme for $270m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQbDVTN2cxcC1EaERad053LXEtWUthSER1UC1hNGs0V2ZOdGNVYURELUNNb3ZBOFFXYWNTR2t3ZWZjYXhjNTJ5Tm1BWVprdE55WDZiZTctandva0dhNjA4WnB1bWhuVFkydVhMNFdDQldrcVplWUdBZjZuWFVLcVhSbHVuZEdnNEl6QURDdzM4YmFCVm1ZNTBiYW5nNUZzX2pveHZQaGZjRlFTamplZ1N3bg?oc=5","date":"2025-05-18","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A - Genetic Engineering and Biotechnology News","headline":"StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNU1paajZmQXNjWmNlMHBaVGwtWmhmZ1VQZVN6clNFY204QnFSYXZJMDlubGwwaElyTkR6anVVdmt6UllDTUQ5ZkVzV2FjM1JxelRybWMtcWM2V0FnTVpUUklVd0xMeUR6TC1BVkx1b1pXa1V4MGo0ZHBzemZtNXFQRUUzY1B5V2JSNzE2S0RuWUtZYU1pZG9hVzFXbjA?oc=5","date":"2025-05-16","type":"deal","source":"BioPharma Dive","summary":"BioMarin to buy rare disease drugmaker Inozyme for $270M - BioPharma Dive","headline":"BioMarin to buy rare disease drugmaker Inozyme for $270M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5xODBaeW5BMENEelpGSlg2SE1aM2h5WUxDZXpIZTAwanpMUmlkc3hab0U4Z0V3WVlzdUh6eU13eW1sdTdwNVZ0M0RDVUNwYkhkNDNv?oc=5","date":"2025-05-16","type":"deal","source":"FirstWord Pharma","summary":"BioMarin grows enzyme portfolio with $270M Inozyme buy - FirstWord Pharma","headline":"BioMarin grows enzyme portfolio with $270M Inozyme buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxONVdvYi1ORnBCSEhocWxNYWZoNTNNNllrbTNxWXRJb2RuV3RQQklOcURpWWZiczg2SG9tZF94LTFndlpKLWRRMVh3aXJkcXRmZUtRTVNKSV9sZDYzVUkwVjBzQnExUkotcFVBRndITTZ0dDJOWWxxOEQ1RUNLOVNPSVBYN2FJbEZaSTZFeVRhRUF1MjZEdk10TDF1dDI2amFjSU9NRmEwT2UwNXRzaFJ1bDdsY0xMUlAxMERwYw?oc=5","date":"2025-05-16","type":"trial","source":"Fierce Biotech","summary":"BioMarin inks $270M Inozyme buyout, bagging phase 3 prospect in first M&A move of the Sabry era - Fierce Biotech","headline":"BioMarin inks $270M Inozyme buyout, bagging phase 3 prospect in first M&A move of the Sabry era","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQQ2kybldBR3Z1V3NrTWdfUEJ6bzNBZzZsX3o2VUNfWnhEQjR3UmluYV92RXhVX081RF9BR043RTBZX2NIRUZlMnJkUTNrblQzX3VCYW5fanB5N3hNemlfaTY0Q2VqQjJzUEdTUDlNeVNySlg5U2FOWG0yajVVYWY1R0tEemREM0FMamc1WVNlbTMtcjhfY1lfRUtSb3ZzZE41Sm9TVjl4S0VSalgy?oc=5","date":"2025-05-16","type":"pipeline","source":"MedCity News","summary":"BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease - MedCity News","headline":"BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQN21KdVBUbmFKQXpIc2hxVW56REVNbW9tQVU1TXM1SUNITzg5TXVjZHk0WWQ1dWtUZGhEOEhQWDRicDREWEY1OS1IMF9qeE1WWF9DLXFvMFBNVzZaVWVIV2w0SDU1bmxqaUstV3hpT01NOTRWUXNwLVY3a3NOc2RhQWdwa0dKcUVDODVpRDM1QWhMeUR5ZTVqSDFMeGNxNDBNMk93aA?oc=5","date":"2025-05-16","type":"pipeline","source":"Investor's Business Daily","summary":"Dollar Stock Skyrockets 179% On BioMarin Takeover - Investor's Business Daily","headline":"Dollar Stock Skyrockets 179% On BioMarin Takeover - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNWXk0bHpENzlpckl6TFFnWlhsS3NZSFE1SVVYWjUtQmV0Q3BkTWFyelRveGJDWFdMRXMyY0R1MG1oVDY5QXVDZzJmZHRKekxDNjlDa0d4emEycWdrVzN5aHFGTWRJVU40QmdmS2p0YnBPdUZadFlUdU9vaktEQkJicWlCcVdtbU5EQU45SGdoSzNvdjA?oc=5","date":"2025-05-16","type":"deal","source":"BioSpace","summary":"BioMarin Expands Enzyme Expertise With $270M Inozyme Buy - BioSpace","headline":"BioMarin Expands Enzyme Expertise With $270M Inozyme Buy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":83231000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-102024000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":21081000,"cashHistory":[],"totalAssets":123182000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}